| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0014-2999(88)90110-0 |
| P698 | PubMed publication ID | 3384000 |
| P2093 | author name string | Ungerstedt U | |
| Collin AK | |||
| Sharp T | |||
| Zetterström T | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dopamine | Q170304 |
| striatum | Q1319792 | ||
| P304 | page(s) | 327-334 | |
| P577 | publication date | 1988-04-01 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. | |
| P478 | volume | 148 |
| Q24535639 | "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment |
| Q48175366 | 5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats |
| Q48355277 | 5-HT-moduline, a 5-HT(1B/1D) receptor endogenous modulator, interacts with dopamine release measured in vivo by microdialysis |
| Q42708791 | 5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo |
| Q67915393 | Active transport pumps of HVA and DOPAC in dopaminergic nerve terminals |
| Q48471325 | Acute and sustained effects of methylphenidate on cognition and presynaptic dopamine metabolism: an [18F]FDOPA PET study. |
| Q72319565 | Acute effects of sigma ligands on the extracellular DOPAC level in rat frontal cortex and striatum |
| Q43498727 | Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study |
| Q35206689 | Acute oral administration of low doses of methylphenidate targets calretinin neurons in the rat septal area. |
| Q42440487 | Alterations in the spontaneous release of dopamine and the density of the DA D2 receptor mRNA after chronic postnatal exposure to cocaine |
| Q42555248 | Altered in vivo catecholamine release in the hypothalamic paraventricular nucleus of the aged rat. |
| Q48477488 | Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens |
| Q34359201 | Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. |
| Q41334106 | Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. |
| Q35007563 | Appetite and reward |
| Q52167465 | Behavioral and mesocorticolimbic dopamine responses to non aggressive social interactions depend on previous social experiences and on the opponent's sex. |
| Q42452196 | Biotransformation of locally applied precursors of dopamine, serotonin and noradrenaline in striatum and hippocampus: a microdialysis study |
| Q48568688 | Brain microdialysis in rats: a technique to reveal competition in vivo between endogenous dopamine and moclobemide, a RIMA antidepressant |
| Q59576450 | Changes in extracellular levels of dopamine metabolites in somatosensory cortex after peripheral denervation |
| Q32065087 | Changes in striatal electroencephalography and neurochemistry induced by kainic acid seizures are modified by dopamine receptor antagonists |
| Q48667897 | Characterization and Pharmacological Responsiveness of Dopamine Release Recorded by Microdialysis in the Substantia Nigra of Conscious Rats |
| Q35027572 | Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat. |
| Q48510354 | Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study. |
| Q33933568 | Chronic nicotine administration in the drinking water affects the striatal dopamine in mice |
| Q48884159 | Chronic nicotine treatment changes differentially the effects of acute nicotine on the three main dopamine metabolites in mouse striatum |
| Q41135565 | Chronic treatment with D1 and D2 dopamine receptor agonists: combined treatments interact to differentially affect brain levels of monoamines |
| Q42461214 | Comparative effects of pesticides on in vivo dopamine release in freely moving rats. |
| Q42099064 | Controlled cortical impact injury influences methylphenidate-induced changes in striatal dopamine neurotransmission. |
| Q39394930 | D-amino acid oxidase is expressed in the ventral tegmental area and modulates cortical dopamine |
| Q44074028 | Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats |
| Q49018889 | Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis |
| Q44539125 | Differential effects of post-implantation time on potassium- versus D-amphetamine-evoked dopamine overflow in the striatum of F344 rats |
| Q71227069 | Differential regional and kinetics effects of piribedil and bromocriptine on dopamine metabolites: a brain microdialysis study in freely moving rats |
| Q42458272 | Differential regulation of dopamine release by N-methyl-D-aspartate receptors in rat striatum after partial and extreme lesions of the nigro-striatal pathway |
| Q90073611 | Direct in Vivo Electrochemical Detection of Resting Dopamine Using Poly(3,4-ethylenedioxythiophene)/Carbon Nanotube Functionalized Microelectrodes |
| Q35142888 | Dissociable rate-dependent effects of oral methylphenidate on impulsivity and D2/3 receptor availability in the striatum |
| Q42450338 | Dizocilpine (MK-801) and tetrodotoxin influence accumbal dopamine release evoked by intrapallidal morphine |
| Q48638008 | Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats |
| Q43878447 | Dopac distribution and regulation in striatal dopaminergic varicosities and extracellular space |
| Q28585149 | Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum |
| Q34098136 | Dopamine and noradrenaline release in the prefrontal cortex in relation to unconditioned and conditioned stress and reward |
| Q72222117 | Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity |
| Q72567166 | Dopaminergic function in rat brain after oral administration of calcium-channel blockers or haloperidol. A microdialysis study |
| Q44595872 | Dopaminergic innervation of the rat globus pallidus characterized by microdialysis and immunohistochemistry |
| Q35754193 | Dopaminergic toxicity of the herbicide atrazine in rat striatal slices |
| Q48407897 | Effect of N-methyl-D-aspartate and potassium on striatal monoamine metabolism in immature rat: an in vivo microdialysis study |
| Q41510296 | Effect of acute millimeter wave exposure on dopamine metabolism of NGF-treated PC12 cells |
| Q35041069 | Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo |
| Q44150894 | Effect of ouabain applied by intrastriatal microdialysis on the in vivo release of dopamine, acetylcholine, and amino acids in the brain of conscious rats |
| Q48859358 | Effect of prior ethanol experience on dopamine overflow in accumbens of AA and ANA rats |
| Q41135964 | Effect of the dopamine D2 receptor agonist quinpirole on the in vivo release of dopamine in the caudate nucleus of hypertensive rats |
| Q72094442 | Effect of transient reduction of cerebral blood flow in normotensive rats on striatal dopamine-release |
| Q48404055 | Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats |
| Q37227997 | Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo |
| Q28266549 | Effects of a psychostimulant drug sydnocarb on rat brain dopaminergic transmission in vivo |
| Q48787628 | Effects of acute and chronic morphine on DOPAC and glutamate at subcortical DA terminals in awake rats |
| Q43978501 | Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat. |
| Q41141018 | Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens |
| Q40957166 | Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine |
| Q41136706 | Effects of insulin on hypothalamic monoamine metabolism |
| Q48660311 | Effects of interleukin-1beta and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study |
| Q48170839 | Effects of kainic acid, quisqualic acid, and their antagonist, pCB-PzDA, on rat electrocorticograms and monoamine metabolite levels in rat striatum |
| Q48125529 | Effects of partial dopamine loss in the medial prefrontal cortex on local baseline and stress-evoked extracellular dopamine concentrations |
| Q42454867 | Effects of prenatal methylazoxymethanol treatment on striatal dopaminergic systems in rat brain |
| Q42479281 | Effects of selective dopamine depletion in medial prefrontal cortex on basal and evoked extracellular dopamine in neostriatum |
| Q48911414 | Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum |
| Q28194974 | Effects of some antioxidative aporphine derivatives on striatal dopaminergic transmission and on MPTP-induced striatal dopamine depletion in B6CBA mice |
| Q41786294 | Effects of taurine, homotaurine and GABA on hypothalamic and striatal dopamine metabolism |
| Q48151790 | Effects of the NMDA receptor antagonist D-CPPene on extracellular levels of dopamine and dopamine and serotonin metabolites in striatum of kindled and non-kindled rats |
| Q49077943 | Effects of transient forebrain ischemia and pargyline on extracellular concentrations of dopamine, serotonin, and their metabolites in the rat striatum as determined by in vivo microdialysis |
| Q49093126 | Enantiomeric differences in the effects of 3,4-methylenedioxymethamphetamine on extracellular monoamines and metabolites in the striatum of freely-moving rats: An in vivo microdialysis study |
| Q48247523 | Enhanced dopamine efflux in the amygdala by a predictive, but not a non-predictive, stimulus: facilitation by prior repeated D-amphetamine |
| Q42509327 | Extracellular dopamine and serotonin in the rat striatum during transient ischaemia of different severities: a microdialysis study |
| Q49150122 | Extracellular norepinephrine in the medial hypothalamus increases during feeding in chicks: a microdialysis study |
| Q86649701 | Further contribution to the study of corticostriatal glutamatergic and nigrostriatal dopaminergic interactions within the striatal network: an in vivo voltammetric investigation |
| Q48477073 | Haloperidol 2 mg impairs inhibition but not visuospatial attention |
| Q44645113 | High frequency stimulation of the entopeduncular nucleus has no effect on striatal dopaminergic transmission |
| Q42439729 | High‐frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats |
| Q35116551 | In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease |
| Q41074381 | In vivo analysis of the role of dopamine in stimulant and opiate self-administration. |
| Q44829638 | In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis |
| Q44801222 | In vivo evidence for a concordant response of terminal and dendritic dopamine release during intranigral infusion of drugs |
| Q48958570 | In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain |
| Q48958556 | In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine |
| Q72222115 | In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids |
| Q42026628 | In vivo release of dopamine from rat striatum, substantia nigra and prefrontal cortex: differential modulation by baclofen |
| Q42466864 | In vivo release of neuronal histamine in the hypothalamus of rats measured by microdialysis |
| Q28343012 | Increased Cerebrospinal Fluid Dopamine and 3,4‐Dihydroxyphenylacetic Acid Levels in Huntington's Disease: Evidence for an Overactive Dopaminergic Brain Transmission |
| Q32062378 | Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra |
| Q48510163 | Increased extracellular dopamine in the nucleus accumbens of the rat during associative learning of neutral stimuli |
| Q48257438 | Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. |
| Q35050914 | Intracerebral microdialysis: 30 years as a tool for the neuroscientist |
| Q44936205 | Intrastriatal dialysis evidence for a direct inhibitory effect of benztropine on dopamine re-uptake |
| Q43750237 | Involvement of intrinsic cholinergic and GABAergic innervation in the effect of NMDA on striatal dopamine efflux and metabolism as assessed by microdialysis studies in freely moving rats |
| Q52307779 | Involvement of lateral septum in alcohol's dopamine-elevating effect in the rat. |
| Q42494784 | Local pharmacological manipulation of extracellular dopamine levels in the dorsolateral prefrontal cortex and caudate nucleus in the rhesus monkey: an in vivo microdialysis study |
| Q45902348 | Long-Term Monitoring of Brain Dopamine Metabolism In Vivo with Carbon Paste Electrodes. |
| Q28263277 | Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter |
| Q47852599 | Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) Elevates Stimulus-Evoked Release of Dopamine in Freely-Moving Rats |
| Q48467181 | Mesocorticolimbic dopamine systems: cross-sensitization between stress and cocaine |
| Q46690279 | Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists |
| Q22241805 | Methyiphenidate vs. amphetamine: Comparative review |
| Q44506378 | Microdialysis studies of D-amphetamine-evoked striatal dopamine overflow in young versus aged F344 rats: effects of concentration and order of administration |
| Q73634982 | Modulation of dihydroxyphenylacetaldehyde extracellular levels in vivo in the rat striatum after different kinds of pharmacological treatment |
| Q33812955 | Neurturin effects on nigrostriatal dopamine release and content: comparison with GDNF |
| Q48446835 | Norepinephrine efflux evoked by potassium chloride in cat sympathetic nerves: dual mechanism of action |
| Q51605901 | Novelty-induced increase in dopamine release in the rat prefrontal cortex in vivo: inhibition by diazepam |
| Q37810236 | Ocular Microdialysis: A Continuous Sampling Technique to Study Pharmacokinetics and Pharmacodynamics in The Eye |
| Q34794235 | On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons? |
| Q48489177 | On the use of multiple probe insertions at the same site for repeated intracerebral microdialysis experiments in the nigrostriatal dopamine system of rats |
| Q37184589 | Osmotic release oral system-methylphenidate improves neural activity during low reward processing in children and adolescents with attention-deficit/hyperactivity disorder |
| Q34190861 | Overview of brain microdialysis |
| Q36882433 | Overview of microdialysis |
| Q43656923 | Oxygen inhalation enhances striatal dopamine metabolism and monoamineoxidase enzyme inhibition prevents it: a microdialysis study |
| Q43260115 | P-glycoprotein inhibition potentiates the behavioural and neurochemical actions of risperidone in rats. |
| Q42540454 | Peptide N- and P/Q-type Ca2+ blockers inhibit stimulant-induced hyperactivity in mice |
| Q34118080 | Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease |
| Q34982551 | Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine |
| Q24811171 | Polychlorinated biphenyls alter extraneuronal but not tissue dopamine concentrations in adult rat striatum: an in vivo microdialysis study |
| Q44515029 | Potentiated reinstatement of cocaine-seeking behavior following D-amphetamine infusion into the basolateral amygdala |
| Q28508907 | Profound neuronal plasticity in response to inactivation of the dopamine transporter |
| Q27308060 | Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice |
| Q48667823 | Prolonged Alterations in Canine Striatal Dopamine Metabolism Following Subtoxic Doses of l-Methyl-4-Phenyl- 1,2,3,6-Tetrahydropyridine (MPTP) and 4'-Amino-MPTP Are Linked to the Persistence of Pyridinium Metabolites |
| Q48828694 | R(+)-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex |
| Q30466473 | Rapid effects of hearing song on catecholaminergic activity in the songbird auditory pathway |
| Q42476651 | Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. |
| Q48567304 | Reduced striatal tyrosine hydroxylase activity is not accompanied by change in responsiveness of dopaminergic receptors following chronic treatment with deprenyl |
| Q42475696 | Responsiveness of striatal dopamine release in awake animals after chronic 1-methyl-4-phenylpyridinium ion-induced lesions of the substantia nigra |
| Q93001627 | Review Article: Tools and trends for probing brain neurochemistry |
| Q48949037 | Role of Adenylate Cyclase in the Modulation of the Release of Dopamine: A Microdialysis Study in the Striatum of the Rat |
| Q48127929 | Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation |
| Q42482728 | Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum |
| Q48722396 | Selective decrease in extracellular DOPAC concentrations in rat striatum following in vivo dialysis with low concentrations of MPP+ |
| Q34804462 | Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity |
| Q48168018 | Stereospecific distribution of methylphenidate enantiomers in rat brain: specific binding to dopamine reuptake sites |
| Q42490762 | Stress-induced dopamine release in the neostriatum: evaluation of the role of action potentials in nigrostriatal dopamine neurons or local initiation by endogenous excitatory amino acids |
| Q42504689 | Stress-induced increase in extracellular dopamine in striatum: role of glutamatergic action via N-methyl-D-aspartate receptors in substantia nigra |
| Q48527328 | Striatal and urinary DOPAC/DA ratio may indicate a long-lasting DA release enhancement by MPP+ and MPTP. |
| Q42440179 | Suppressive effects of trihexyphenidyl on methamphetamine‐induced dopamine release as measured by in vivo microdialysis |
| Q67662443 | Tail pinch-induced changes in the turnover and release of dopamine and 5-hydroxytryptamine in different brain regions of the rat |
| Q51580785 | Taurine infused intrastriatally elevates, but intranigrally decreases striatal extracellular dopamine concentration in anaesthetised rats. |
| Q69617757 | The K+-induced increases in noradrenaline and dopamine release are accompanied by reductions in the release of their intraneuronal metabolites from the rat anterior hypothalamus. An in vivo brain microdialysis study |
| Q48705643 | The effects of bupropion in vivo in the neostriatum of 5-day-old and adult rats |
| Q42478845 | The in vivo modulation of dopamine synthesis by calcium ions: influences on the calcium independent release |
| Q37924850 | The in vivo neurochemistry of the brain during general anesthesia |
| Q48753360 | The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons |
| Q44374208 | The role of GABA(A) receptors in the neural systems of the medial preoptic area in the control of GnRH release in ewes during follicular phase. |
| Q48521627 | The selective inhibition of the D₁ dopamine receptor results in an increase of metabolized dopamine in the rat striatum. |
| Q44111455 | The selective serotonin(1A)-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase |
| Q48399686 | Unique activation of extracellular striato-pallidal neurotransmitters in rats following acute risperidone |
| Q48190539 | Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment |
Search more.